Certificate under Regulation. 74(5) of SEBI DP Act 2018 for the Quarter ended 31st December, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eiko Lifesciences Ltd has submitted a compliance certificate under SEBI Regulation 74(5) for the quarter ended 31 December 2025. The certificate was issued by Bigshare Services Pvt. Ltd., the company's Registrar and Share Transfer Agent. Bigshare confirmed that the company received no dematerialisation requests (i.e., no requests to convert physical shares into electronic/demat form) during the period from 1 October 2025 to 31 December 2025. The filing was signed by Chintan Doshi, Company Secretary, on 9 January 2026.
This is a routine quarterly compliance filing with no material impact on shareholders or the stock price. It simply confirms there was no demat-related activity to report for the quarter and helps the company stay compliant with SEBI depositary regulations.